A 6-week open-label, randomized, multicentre, phase IIIb, parallel-group study, which describes the renal effects of the lipid-regulating agents rosuvastatin and simvastatin in the treatment of subjects with Fredrickson type IIa and IIb dyslipidaemia, including heterozygous familial hypercholesterolemia

Trial Profile

A 6-week open-label, randomized, multicentre, phase IIIb, parallel-group study, which describes the renal effects of the lipid-regulating agents rosuvastatin and simvastatin in the treatment of subjects with Fredrickson type IIa and IIb dyslipidaemia, including heterozygous familial hypercholesterolemia

Not stated
Phase of Trial: Phase III

Latest Information Update: 28 Mar 2006

At a glance

  • Drugs Rosuvastatin; Simvastatin
  • Indications Dyslipidaemias; Hypercholesterolaemia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 28 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top